- Report
- January 2024
- 200 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- May 2023
- 212 Pages
Global
From €3795EUR$3,900USD£3,251GBP
- Report
- March 2024
- 195 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- April 2024
- 196 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- January 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- January 2024
- 148 Pages
Global
From €3794EUR$3,899USD£3,250GBP
- Report
- February 2024
- 177 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- January 2024
- 150 Pages
Global
From €4719EUR$4,850USD£4,043GBP
- Report
- October 2023
- 177 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- January 2024
- 171 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- August 2023
- 116 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- October 2023
- 145 Pages
Global
From €3065EUR$3,150USD£2,626GBP
- Report
- April 2023
- 192 Pages
North America
From €7774EUR$7,990USD£6,660GBP
- Report
- April 2023
- 306 Pages
Europe
From €7774EUR$7,990USD£6,660GBP
- Report
- April 2023
- 306 Pages
Asia Pacific
From €7774EUR$7,990USD£6,660GBP
- Report
- December 2020
- 207 Pages
Global
From €1338EUR$1,375USD£1,146GBP
€2676EUR$2,750USD£2,292GBP
The Kidney Transplant market is a subset of the biotechnology industry that focuses on the development of treatments and technologies related to kidney transplantation. This includes the development of new drugs, medical devices, and surgical techniques to improve the safety and efficacy of kidney transplantation. Additionally, the market includes research into the development of new immunosuppressive drugs to reduce the risk of organ rejection.
The Kidney Transplant market is highly competitive, with many companies vying for a share of the market. Companies in the market include Astellas Pharma, Novartis, Roche, Merck, and Pfizer. Additionally, there are a number of smaller companies that specialize in the development of new treatments and technologies related to kidney transplantation. Show Less Read more